AMCP Press & News
Stay up-to-date with the latest press and news releases, covering significant updates and actions taken by AMCP. Explore comprehensive articles, statements, and announcements that highlight the organization's efforts and achievements. Stay connected with important developments and insights from the world of managed care pharmacy.
Latest Press Releases
AMCP In the News
Last week, nearly 40 experts and key stakeholders in the managed care setting convened for AMCP’s Partnership Forum: High-Investment Medications.
During AMCP Foundation's 2022 National P&T Competition, the University of Michigan received the first place prize. The competition convened student pharmacists from around the country to develop a formulary drug monograph, considering evidence gaps; value; health equity; and utilization management tools.
AMCP Foundation announces Best Poster recipients during AMCP 2022. This semiannual competition culminates twice per year at AMCP national meetings, with awards for new practitioners presented in three categories.
Mason Johnson, BS, PharmD candidate, will serve as the 2022–2023 Executive Fellow in Health Care Association Leadership. His fellowship will begin July 1, 2022.
AMCP applauds Senators Moore Capito (R-WV) and Shaheen (D-NH) and Congressmen Thompson (D-CA-5) and McKinley (R-WV-1) on the introduction of the bipartisan Access to Prescription Digital Therapeutics Act.
AMCP applauds Congressman Brett Guthrie on the introduction of the Pre-approval Information Exchange (PIE) Act of 2022.
Mark McClellan, MD, PhD, was recently named 2022 Steven G. Avey Award recipient. The Avey award recognizes a managed care leader for sustained, exemplary, and distinguished service to the practice of pharmacy.
AMCP congratulates Robert Califf, MD, MACC, on his appointment as Commissioner of the U.S. Food and Drug Administration.
AMCP has recently published a manuscript in the Journal of Managed Care + Specialty Pharmacy (JMCP) focusing on the significant role that health plans, managed care organizations, prescribers, pharmacists, patients, and others have in decreasing the morbidity and mortality associated with opioid overdose.
AMCP announces the election of four members to the AMCP Board of Directors for the 2022-2023 term.
New principles promote the use of pay-for-performance arrangements that lead to improved patient outcomes.
Nearly 40 experts representing payers, pharmacy benefit managers, integrated delivery systems, patient advocates, academicians, and other key stakeholders in the managed care setting convened for AMCP’s Partnership Forum Addressing Evidence Gaps in the Expedited Review Process: Payer Perspectives.
